Logo image of MB

MASTERBEEF GROUP (MB) Stock Fundamental Analysis

NASDAQ:MB - Nasdaq - KYG6001H1011 - Common Stock - Currency: USD

4.39  +0.02 (+0.46%)

Fundamental Rating

1

MB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. MB has a bad profitability rating. Also its financial health evaluation is rather negative. MB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MB had negative earnings in the past year.
MB Yearly Net Income VS EBIT VS OCF VS FCFMB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 50M 100M

1.2 Ratios

Industry RankSector Rank
ROA -11.67%
ROE -104.54%
ROIC 3.85%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MB Yearly ROA, ROE, ROICMB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 200 400 600 800

1.3 Margins

Industry RankSector Rank
OM 0.88%
PM (TTM) N/A
GM 63.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MB Yearly Profit, Operating, Gross MarginsMB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MB is destroying value.
The number of shares outstanding for MB remains at a similar level compared to 1 year ago.
The debt/assets ratio for MB has been reduced compared to a year ago.
MB Yearly Shares OutstandingMB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
MB Yearly Total Debt VS Total AssetsMB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.94 indicates that MB is not a great score, but indicates only limited risk for bankruptcy at the moment.
MB has a Debt/Equity ratio of 1.88. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF N/A
Altman-Z 2.94
ROIC/WACC0.48
WACC8.05%
MB Yearly LT Debt VS Equity VS FCFMB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

MB has a Current Ratio of 0.80. This is a bad value and indicates that MB is not financially healthy enough and could expect problems in meeting its short term obligations.
MB has a Quick Ratio of 0.80. This is a bad value and indicates that MB is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.74
MB Yearly Current Assets VS Current LiabilitesMB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

MB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -212.08%.
MB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.55%.
EPS 1Y (TTM)-212.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%353.7%
Revenue 1Y (TTM)16.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.95%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MB Yearly Revenue VS EstimatesMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 100M 200M 300M 400M 500M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MB Price Earnings VS Forward Price EarningsMB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.38
MB Per share dataMB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MASTERBEEF GROUP

NASDAQ:MB (5/27/2025, 4:30:01 PM)

4.39

+0.02 (+0.46%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0.03%
Ins OwnersN/A
Ins Owner Change0%
Market Cap75.33M
AnalystsN/A
Price TargetN/A
Short Float %0.19%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 16.48
P/tB 16.48
EV/EBITDA 7.38
EPS(TTM)-0.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.96
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.67%
ROE -104.54%
ROCE 4.36%
ROIC 3.85%
ROICexc N/A
ROICexgc N/A
OM 0.88%
PM (TTM) N/A
GM 63.59%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF N/A
Debt/EBITDA 0.76
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.74
Altman-Z 2.94
F-ScoreN/A
WACC8.05%
ROIC/WACC0.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-212.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%353.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.15%
OCF growth 3YN/A
OCF growth 5YN/A